| Product Name | Dihydronicotinamide Riboside (NRH) |
|---|---|
| CAS Number | 19132-12-8 |
| Molecular Formula | C₁₁H₁₈N₂O₄ |
| Molecular Weight | 242.27 g/mol |
| Appearance | White to off-white powder |
| Assay (HPLC) | ≥ 98.0% |
| Loss on Drying | ≤ 5.0% |
Need help? Contact our team
Dihydronicotinamide Riboside (NRH) is a reduced form of nicotinamide riboside (NR) and a novel member of the vitamin B₃ family.
It serves as a highly efficient precursor to NAD⁺ (nicotinamide adenine dinucleotide), the essential coenzyme involved in cellular energy metabolism, DNA repair, and redox signaling.
NRH has gained significant attention in recent years due to its superior efficacy compared to other NAD⁺ precursors, including NR and NMN (nicotinamide mononucleotide).
Studies suggest that NRH can elevate NAD⁺ levels more rapidly and at lower doses, making it a promising candidate for anti‑aging, metabolic health, and mitochondrial support applications.
| Compound | CAS No. | Relationship |
|---|---|---|
| Dihydronicotinamide Riboside (NRH) | 19132-12-8 | Reduced, highly active NAD⁺ precursor |
| Nicotinamide Riboside (NR) | 1341-23-7 | Oxidized form, NAD⁺ precursor |
| Nicotinamide Mononucleotide (NMN) | 1094-61-7 | NAD⁺ precursor |
| Nicotinamide Adenine Dinucleotide (NAD⁺) | 53-84-9 | Active coenzyme |
Purity: ≥98.0% (HPLC)
Monthly capacity: 5+ kg
Lead time: 3–5 days (samples), 10–15 days (bulk)
Documentation: COA,HPLC chromatogram, stability data, NMR (upon request)
LyvBio Co., Ltd.
Email: info@lyvbio.com
Website: https://www.lyvbio.com
English English 
Russian
French
Korean
German
Polish
Japanese
Spanish
Italian
Vietnamese